Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis

NCT01755507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG: norUDCA
DRUG: Placebo

Sponsor

Dr. Falk Pharma GmbH